Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

• Main Authors: Christiana Smith (Author), Adriana Weinberg (Author), Jeri E. Forster (Author), Myron J. Levin (Author), Jill Davies (Author), Jennifer Pappas (Author), Kay Kinzie (Author), Emily Barr (Author), Suzanne Paul (Author), Elizabeth J. McFarland (Author)
• Format: Book
• Published: Hindawi Limited, 2016-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Combination antiretroviral therapy (cART) is successfully used for prevention of perinatal HIV transmission. To investigate safety, we compared adverse events (AE) among infants exposed to different maternal cART regimens. We reviewed 158 HIV-uninfected infants born between 1997 and 2009, using logi...